ArticleBMC public health2025
Regional epidemiological study of hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfections of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) are leading contributors to Indonesia's disease burden, particularly among prisoners with limited access to care. This study investigates the prevalence and risk factors of these infections in prisoners of Semarang. DESIGN AND
methodsA cross-sectional study at Kedungpane prison, Semarang, Central Java, Indonesia included informed consent, questionnaires about awareness and risk factors, and blood tests. HBV and HCV were determined through rapid serological methods, whereas HIV was confirmed with three rapid tests.
resultsAmong 1,642 prisoners (mean age 35.1 years), HBV, HCV and HIV prevalence was 3.3%, 1.5% and 0.9%, respectively. Significant risk factors for HCV included commercial sex workers (p = 0.009), people who inject drugs (PWID) (p = 0.000), blood transfusions (p = 0.025), drug use (p = 0.007), and multiple partners (p = 0.005). For HIV, key factors were being a transgender women (p = 0.037) and PWID (p = 0.001). Although 94.3% of prisoners had HIV screening, only 12 out of 15 HIV-positive prisoners understood their diagnosis and received treatment. The awareness levels were higher for HIV (76%) than for HBV (35.3%) and HCV (30.7%), with most information from media (51.2%) and counseling (30.4%). In the multivariate analysis, confirmed using exact logistic regression, only PWID remained independently associated with HCV infection, while both PWID and being a transgender woman were independently associated with HIV infection. These associations were strong but should be interpreted cautiously due to limited event counts.
conclusionsPrisoners had the highest prevalence of HBV, followed by HCV and HIV, with HCV rates higher than WHO data. Risk behaviors involved drug use and multiple sexual partners, and knowledge of HIV was higher than that of HBV and HCV mainly from social media and television.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.